www.spectrx.com - SpectRx, Inc. Bill Wells, 770-242-8723 A new non-invasive test that scans for cervical cancer, being developed by SpectRx, Inc. (Pink Sheets: SPRX), may lead to earlier detection of cervical disease in women of developing countries that lack the infrastructure to perform Pap or human papilloma virus (HPV) testing.